Tenecteplase for Ischemic Stroke due to Large Vessel Occlusion at 4.5 to 24 Hours: A Meta‐Analysis of Randomized Controlled Trials
This meta-analysis of randomized controlled trials manifested that tenecteplase within a 4.5- to 24-h time window of large vessel occlusion stroke was superior to control for an excellent functional outcome (mRS 0-1) without safety concerns.
Authors
- Yujie Ma
- Yizhe Tang (ORCID: https://orcid.org/0000-0001-5354-478X)
- Manjun Hao (ORCID: https://orcid.org/0000-0003-1639-6102)
- Kejia Shen
- Liyuan Wang (ORCID: https://orcid.org/0000-0003-2718-6450)
- Shuangzhe Wu
- Yige Zhang (ORCID: https://orcid.org/0000-0001-6213-1899)
- Na Wu (ORCID: https://orcid.org/0000-0003-4560-0053)
- Zhixin Li (ORCID: https://orcid.org/0000-0003-2549-5559)
- Zhixin Cao
- Yunyun Xiong
Institutions
- Capital Medical University (CN)
- Beijing Tian Tan Hospital (CN)
- National Clinical Research Center for Digestive Diseases (CN)
- Chinese Institute for Brain Research (CN)
Publication Details
- Journal
- Brain and Behavior
- Published
- 2025-11-01
- DOI
- https://doi.org/10.1002/brb3.71037
- Primary Topic
- Acute Ischemic Stroke Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00